AMA encourages widespread e-prescribing adoption with uniform standards

The American Medical Association (AMA) outlined key steps to move forward with broader adoption of e-prescribing at a meeting with stakeholders held May 9 at the Brookings Institution in Washington, D.C.

The AMA has reached out to physicians across the country to better understand the challenges that must be addressed to facilitate rapid, widespread adoption of e-prescribing by physicians.

AMA board member and emergency physician Steven Stack, MD, discussed the AMA's work to address adoption barriers among physicians and the important role e-prescribing will play in transforming healthcare.

"Every day more physicians across the country are using e-prescribing or are in the process of implementing the technology," said Stack. "To help more physicians take advantage of e-prescribing, financial incentives are needed to offset the costs of implementation."

The AMA supports a national framework that includes a uniform set of e-prescribing standards and a transitional period for physicians to adopt the technology.

"Any e-prescribing requirement that triggers potential penalties should be deferred until two years after final standards are in place," said Stack. "This will allow physicians to acquire and implement e-prescribing tools and train their staff."

“The AMA supports efforts to advance e-prescribing adoption among physicians," Stack continued. “E-prescribing can serve as a means to improve patient safety, enhance care coordination among healthcare providers and reduce administrative burdens that take physicians away from patients.”

"Healthcare leaders must work together to ensure the infrastructure is fully prepared to advance e-prescribing," he concluded. "The AMA will continue to work to promote the widespread adoption of e-prescribing in a manner benefiting all relevant stakeholders, particularly America's patients.”

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.